Drug Type Recombinant protein |
Synonyms CT-400 (Creabilis Therapeutics) |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | IT | - | |
Nervous System Diseases | Preclinical | FR | - | |
Autoimmune Diseases | Discovery | FR | - | |
Autoimmune Diseases | Discovery | IT | - | |
Cardiovascular Diseases | Discovery | IT | - | |
Cardiovascular Diseases | Discovery | FR | - | |
Infectious Diseases | Discovery | FR | - | |
Neoplasms | Discovery | FR | - | |
Neoplasms | Discovery | IT | - | |
Sepsis | Discovery | IT | - |